Point72 Asset Management
GOSS icon

Point72 Asset Management’s Gossamer Bio GOSS Stock Holding History

Point72 Asset Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-125,000
Closed -$388K – 4059
2025
Q4 		$388K Buy
125,000
+100,000
+400% +$285K ﹤0.01% 3361
2025
Q3 		$65.8K Buy
+25,000
New +$55.1K ﹤0.01% 2226

Other funds holding GOSS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Point72 Asset Management's GOSS Position: Q3 2023 in Review

Point72 Asset Management sold out of Gossamer Bio (GOSS) in Q3 2023, closing a stake of 34,917 shares — an estimated $41.9K sold.

Point72 Asset Management first reported a position in GOSS in Q2 2019 and held it in 4 quarters. The position peaked at $8.06M in Q2 2022. 95 funds tracked by Wall St. Rank hold GOSS as of Q3 2023.

  • Point72 Asset Management reported no remaining Gossamer Bio position as of Q3 2023 after selling out during the quarter.
  • Point72 Asset Management sold 34,917 Gossamer Bio shares in Q3 2023, an estimated $41.9K.
  • Point72 Asset Management first reported a position in Gossamer Bio in Q2 2019 and held it in 4 quarters.
  • Point72 Asset Management's Gossamer Bio position peaked at $8.06M in Q2 2022.
  • 95 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2023.

Based on Point72 Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.